LY2140023 in people with Schizophrenia
Researchers are comparing LY2140023 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including Wichita
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers are comparing LY2140023 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including WichitaA 17-Week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment With LY2140023 Combined With Standard of Care (SOC) Compared to Placebo With SOC in the Treatment of Patients With Prominent Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveSafety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Multiple-Ascending Doses of LY2979165 in Healthy Subjects
This study has finished and is no longer accepting participants.
In SingaporeA Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems
Read the official source — NCT05599126This study evaluates the effectiveness of Mianserin for people with depression.
Current recruitment status is unconfirmed.
In ShanghaiThis study evaluates the safety and effectiveness of mifepristone for people with depression.
This study ended early.
Multiple locations, including Little RockThis study evaluated the safety of MK-5720 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleMoral Distress, Moral Injury and Post-Traumatic Stress Among Mayo Clinic Nurses
This study is by invitation only.
Multiple locations, including PhoenixTolerability, Pharmacokinetics, and Efficacy of MP-101 in the Treatment of Patients With Dementia-Related Psychosis and/or Agitation and Aggression
This study ended early.
Multiple locations, including PhoenixA Pilot Study of N-acetylcysteine for Alcohol Use Disorder
This study was withdrawn before enrollment.
Location not clearly listedThis study evaluated the safety and effectiveness of ND0801 for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including HaifaAuricular Percutaneous Electrical Neural Field Stimulation in Short-Term Treatment of Alcohol Dependence- Neurohaemodynamic Correlates and Feasibility Study
This study has finished and is no longer accepting participants.
In BengaluruResearchers compared Rapid-Acting Intramuscular Olanzapine and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AichiWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.